Changeflow GovPing Healthcare & Life Sciences US Patent Application for Heart Boosting Formul...
Routine Notice Added Draft

US Patent Application for Heart Boosting Formulation

Favicon for changeflow.com USPTO Patent Applications - Therapeutics (A61P)
Published
Detected
Email

Summary

The USPTO has published a new patent application (US20260083806A1) for a heart boosting formulation. The application details a specific composition including L-carnitine, alpha-linolenic acid, citrulline, vitamin D3, lycopene, holy basil, cinnamon, and beetroot, along with related manufacturing methods. The filing date was September 16, 2025.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a publication of a United States patent application, specifically application number US20260083806A1, filed on September 16, 2025. The application describes a 'heart boosting formulation' comprising a specific list of ingredients including L-carnitine, alpha-linolenic acid, citrulline, vitamin D3, lycopene, holy basil, cinnamon, and beetroot, as well as related methods of manufacture.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future intellectual property protection for a novel therapeutic formulation. Companies involved in the development or manufacturing of cardiovascular supplements or pharmaceuticals should be aware of this filing as it may impact future market exclusivity or licensing opportunities.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

Heart boosting formulation and related methods of manufacture

Application US20260083806A1 Kind: A1 Mar 26, 2026

Inventors

Kedar Prasad

Abstract

A heart boosting formulation comprises: L-carnitine, alpha-linolenic acid, citrulline, vitamin D3, lycopene, holy basil, cinnamon and beetroot.

CPC Classifications

A61K 36/54 A61K 31/01 A61K 31/198 A61K 31/202 A61K 31/205 A61K 31/593 A61K 36/21 A61K 36/53 A61P 9/00

Filing Date

2025-09-16

Application No.

18831814

View original document →

Named provisions

Heart boosting formulation and related methods of manufacture

Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
September 16th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260083806A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Development Formulation Manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11
Topics
Drug Development Dietary Supplements

Get alerts for this source

We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!